234 related articles for article (PubMed ID: 35174865)
21. Predictors of outcome for urethral injection of botulinum toxin to treat detrusor sphincter dyssynergia in men with spinal cord injury.
Soler JM; Previnaire JG; Hadiji N
Spinal Cord; 2016 Jun; 54(6):452-6. PubMed ID: 26712037
[TBL] [Abstract][Full Text] [Related]
22. Botulinum A toxin as a treatment of detrusor-sphincter dyssynergia in patients with spinal cord injury: MRI controlled transperineal injections.
Schurch B; Hodler J; Rodic B
J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):474-6. PubMed ID: 9343126
[TBL] [Abstract][Full Text] [Related]
23. The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction.
Kao YL; Huang KH; Kuo HC; Ou YC
Toxins (Basel); 2019 Dec; 11(12):. PubMed ID: 31847090
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions.
Lee YK; Kuo HC
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31450851
[TBL] [Abstract][Full Text] [Related]
25. Effect of intravesical botulinum neurotoxin-A injection on detrusor hyperreflexia in spinal cord injured patients.
Ge XT; Li YF; Wang Q; Zhao JN
Drug Res (Stuttg); 2015 Jun; 65(6):327-31. PubMed ID: 25350080
[TBL] [Abstract][Full Text] [Related]
26. Treatment of detrusor sphincter dyssynergia by transperineal injection of botulinum toxin.
Gallien P; Robineau S; Verin M; Le Bot MP; Nicolas B; Brissot R
Arch Phys Med Rehabil; 1998 Jun; 79(6):715-7. PubMed ID: 9630155
[TBL] [Abstract][Full Text] [Related]
27. Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: localization with combined fluoroscopic and electromyographic guidance.
Tsai SJ; Ying TH; Huang YH; Cheng JW; Bih LI; Lew HL
Arch Phys Med Rehabil; 2009 May; 90(5):832-6. PubMed ID: 19406304
[TBL] [Abstract][Full Text] [Related]
28. Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury.
Chen SF; Jiang YH; Jhang JF; Kuo HC
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051012
[TBL] [Abstract][Full Text] [Related]
29. Renal deterioration after spinal cord injury is associated with length of detrusor contractions during cystometry-A study with a median of 41 years follow-up.
Elmelund M; Klarskov N; Bagi P; Oturai PS; Biering-Sørensen F
Neurourol Urodyn; 2017 Aug; 36(6):1607-1615. PubMed ID: 27813141
[TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction.
Phelan MW; Franks M; Somogyi GT; Yokoyama T; Fraser MO; Lavelle JP; Yoshimura N; Chancellor MB
J Urol; 2001 Apr; 165(4):1107-10. PubMed ID: 11257648
[TBL] [Abstract][Full Text] [Related]
31. Treatment of detrusor-sphincter dyssynergia by pudendal nerve block in patients with spinal cord injury.
Tsai SJ; Lew HL; Date E; Bih LI
Arch Phys Med Rehabil; 2002 May; 83(5):714-7. PubMed ID: 11994813
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore.
Tow AM; Toh KL; Chan SP; Consigliere D
Ann Acad Med Singap; 2007 Jan; 36(1):11-7. PubMed ID: 17285181
[TBL] [Abstract][Full Text] [Related]
33. Botulinum Toxin A Injection for Autonomic Dysreflexia-Detrusor Injection or Urethral Sphincter Injection?
Chow PM; Kuo HC
Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828422
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y- and vasoactive intestinal polypeptide-containing nerves in the intrinsic external urethral sphincter in the areflexic bladder compared to detrusor-sphincter dyssynergia in patients with spinal cord injury.
Milner P; Crowe R; Burnstock G; Light JK
J Urol; 1987 Oct; 138(4):888-92. PubMed ID: 3656550
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity.
Alvares RA; Silva JA; Barboza AL; Monteiro RT
Int Braz J Urol; 2010; 36(6):732-7. PubMed ID: 21176280
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of intravesical resiniferatoxin in treating detrusor hyper-reflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions.
Kuo HC
BJU Int; 2003 Oct; 92(6):597-601. PubMed ID: 14511042
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity.
Gamé X; Khan S; Panicker JN; Kalsi V; Dalton C; Elneil S; Hamid R; Dasgupta P; Fowler CJ
BJU Int; 2011 Jun; 107(11):1786-92. PubMed ID: 21040367
[TBL] [Abstract][Full Text] [Related]
39. [Detrusor-sphincter dyssynergia and botulinum toxin].
Parratte B; Bonniaud V; Tatu L; Metton G; Michel F; Cosson A; Monnier G
Ann Readapt Med Phys; 2003 Jul; 46(6):319-25. PubMed ID: 12928137
[TBL] [Abstract][Full Text] [Related]
40. External sphincter dyssynergia: an abnormal continence reflex.
Rudy DC; Awad SA; Downie JW
J Urol; 1988 Jul; 140(1):105-10. PubMed ID: 3379672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
